We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Topical Immunotherapy Lowers Risk of Skin Cancer

News   Mar 22, 2019 | Original story from Washington University School of Medicine in St. Louis

 
Topical Immunotherapy Lowers Risk of Skin Cancer

Washington University dermatologist Lynn Cornelius, MD, (left) conducts a skin exam with patient Robert Manchester. Manchester was a participant in a clinical trial testing the effectiveness of a topical immunotherapy against precancerous skin lesions called actinic keratoses, often found on sun-damaged skin. A three-year follow-up analysis suggests the therapy also reduces the risk that the precancerous lesions will progress to skin cancer. Credit: Washington University

 
 
 

RELATED ARTICLES

Broccoli Compound Restores Potent Cancer Cell Suppressor Function

News

Researchers report that indole-3-carbinol (I3C) – a natural compound found in broccoli – can be used to therapeutically target a gene (WWP1) known to play a role in several human cancers.

READ MORE

Antiviral Immunity Differs in Stem Cells

News

A discovery of how stem cells are protected from viruses could inform the development of therapies for use in medicine.

READ MORE

Widely “Inconsistent” Use of Antibodies in Lab Experiments

News

Widespread inconsistencies have been affirmed in the use of a common laboratory procedure, immunohistochemical staining, throwing study results into doubt and shedding light on the “reproducibility crisis”.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE